. 2024 Jul 25;13(4):e240106. doi: 10.1530/ETJ-24-0106
This work is licensed under a Table 3.
pTNM classification and staging according to diagnostic groups. Data are presented as n (%).
| Incidental group (n = 122) | Non-incidental group (n = 103) | P | |
|---|---|---|---|
| T | < 0.01 | ||
| T1a | 17 (13.9) | 14 (13.6) | |
| T1b | 50 (41) | 23 (22.3) | |
| T2 | 41 (33.6) | 30 (29.1) | |
| T3a | 3 (2.5) | 21 (20.4) | |
| T3b | 11 (9) | 11 (10.7) | |
| T4a | 0 (0) | 3 (2.9) | |
| T4b | 0 (0) | 1 (1) | |
| N | 0.357 | ||
| Nx | 73 (59.8) | 52 (50.5) | |
| N0 | 15 (12.3) | 11 (10.7) | |
| N1a | 17 (13.9) | 18 (17.5) | |
| N1b | 17 (13.9) | 22 (21.4) | |
| M | 0.025 | ||
| Mx | 11 (9) | 8 (7.8) | |
| M0 | 111 (91) | 89 (86.4) | |
| M1 | 0 (0) | 6 (5.8) | |
| pTNM staging | 0.069 | ||
| I | 95 (85.6) | 72 (75.8) | |
| II | 16 (14.4) | 18 (18.9) | |
| III | 0 (0) | 2 (2.1) | |
| IVb | 0 (0) | 3 (3.2) | |
| ATA recurrence risk | 0.198 | ||
| Low | 37 (30.3) | 35 (34) | |
| Intermediate | 74 (60.7) | 52 (50.5) | |
| High | 11 (9) | 16 (15.5) |
Values in bold indicate statistical significance.